San Marcos Hospital, Teresina
Urodynamic parameters after hysterectomy are enhanced by bethanechol and cisapride
Published in Pharma Law Weekly, May 23rd, 2006
In a recently published article, researchers in Brazil conducted a study "To evaluate the effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. In this double-blind, placebo-controlled study, 79 patients with cervical cancer were randomized to receive bethanechol (30 mg/day), cisapride (30 mg/day), bethanechol combined with cisapride (same doses) and placebo."
"Urodynamic study was performed, including flowmetry, cystometry, pressure-flow study and urethral pressure profile before radical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-05-23)
More Articles from Pharma Law Weekly
- Business Update
BioScrip named national vendor for Medicare Part B - Business Update
Claimsnet announces contract with Medicare healthcare plan - Healthcare Costs
Weill Cornell awarded major federal contract and grant for public health research - Healthcare Coverage
Lack of health insurance associated with decreased use of health care services - Medicare
Medicare Part D Drug Plan enrollment experience provides valuable lessons for seniors - Medicare
Medicare provides payment increase, policy changes for inpatient psychiatric facilities - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
